Royce & Associates LP Has $56.96 Million Stock Position in Ingevity Corporation $NGVT

Royce & Associates LP decreased its position in Ingevity Corporation (NYSE:NGVT) by 6.1% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 1,032,099 shares of the company’s stock after selling 67,260 shares during the period. Ingevity comprises about 0.6% of Royce & Associates LP’s investment portfolio, making the stock its 23rd biggest holding. Royce & Associates LP owned 2.83% of Ingevity worth $56,962,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Oakworth Capital Inc. purchased a new stake in shares of Ingevity in the third quarter valued at $28,000. Geneos Wealth Management Inc. lifted its stake in Ingevity by 85.8% in the 2nd quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock worth $36,000 after acquiring an additional 387 shares in the last quarter. Headlands Technologies LLC acquired a new stake in Ingevity during the 2nd quarter worth about $46,000. Elevation Point Wealth Partners LLC acquired a new position in shares of Ingevity in the 2nd quarter valued at about $60,000. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Ingevity by 51.6% in the second quarter. EverSource Wealth Advisors LLC now owns 1,616 shares of the company’s stock worth $70,000 after purchasing an additional 550 shares in the last quarter. 91.59% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts recently commented on NGVT shares. Wells Fargo & Company boosted their price objective on shares of Ingevity from $65.00 to $75.00 and gave the company an “equal weight” rating in a research report on Friday. Jefferies Financial Group reiterated a “buy” rating and issued a $82.00 target price on shares of Ingevity in a research report on Thursday. BMO Capital Markets boosted their price target on shares of Ingevity from $64.00 to $70.00 and gave the company an “outperform” rating in a report on Wednesday, December 10th. Zacks Research raised shares of Ingevity to a “hold” rating in a research note on Tuesday, December 16th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Ingevity in a research report on Thursday, January 22nd. Two equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Ingevity has a consensus rating of “Hold” and a consensus target price of $75.67.

Ingevity Stock Performance

Shares of NGVT opened at $71.95 on Friday. The firm has a market cap of $2.59 billion, a price-to-earnings ratio of -15.47 and a beta of 1.34. The company’s fifty day moving average is $67.23 and its 200-day moving average is $59.16. The company has a quick ratio of 0.80, a current ratio of 1.27 and a debt-to-equity ratio of 8.39. Ingevity Corporation has a 12 month low of $28.49 and a 12 month high of $77.46.

Ingevity (NYSE:NGVT) last released its quarterly earnings data on Wednesday, February 25th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.74 by ($0.16). The business had revenue of $255.10 million during the quarter, compared to analyst estimates of $257.27 million. Ingevity had a negative net margin of 13.51% and a positive return on equity of 100.39%. The firm’s revenue for the quarter was down 3.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.95 EPS. Ingevity has set its FY 2026 guidance at 4.800-5.20 EPS. Equities analysts expect that Ingevity Corporation will post 4.45 EPS for the current fiscal year.

About Ingevity

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.